Kangmei Pharmaceutical Co., Ltd., referred to as "Kangmei Pharmaceutical". 1997, founded by private entrepreneur Mr. Ma Xingtian, is located in Puning City, Guangdong Province, formerly known as "Guangdong Kangmei Pharmaceutical Co., Ltd.". In 2000, the share reform began. It is one of the large-scale private pharmaceutical enterprises integrating pharmaceutical supply and marketing, Chinese herbal pieces, Chinese herbal medicines and medical devices. The company passed the share-trading reform.
Kangmei Pharmaceutical was listed in 2002. At its peak, the market value was close to 65.438+0.40 billion, ranking second in the pharmaceutical sector. From the peak to the decline, it is only a few months.
On May 19 and 17, the China Securities Regulatory Commission released the investigation progress, claiming that the financial report for 20 16-20 18 disclosed by Kangmei Pharmaceutical was seriously false, of which 22.58 billion yuan was inflated in 20 16.
In May 2020, the CSRC issued a decision on administrative punishment, in which it was found that Kangmei Pharmaceutical's "20 16 Annual Report" inflated monetary funds by 22.5 billion yuan; Annual report 20 17 inflated monetary funds by 29.9 billion yuan; "20 18 Semi-annual Report" inflated monetary funds by 36.2 billion yuan. Accumulated inflated monetary funds of 88.6 billion yuan. The Company failed to disclose related party transactions of RMB 6,543.8+065,438+06,438.8+09 billion occupied by the controlling shareholder and its related parties in this period as required.
The court made a first-instance judgment on the lawsuit of the special representative of Kangmei Pharmaceutical. The CSI Service Center for Small and Medium Investors, representing more than 50,000 investors of the plaintiff, received compensation of about 2.459 billion yuan. In addition to the listed company itself, in this judgment, from the actual controller of the company, to the senior management, independent directors, and even to the partners and signing accountants of the accounting firm, they must bear joint and several liability for compensation.
In recent days, the handling of this matter has been released one after another, which has once again attracted everyone's attention.